Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Adv Drug Deliv Rev. 2018 Aug 17;134:65–78. doi: 10.1016/j.addr.2018.08.005

Figure 4.

Figure 4.

ApDCs for gene therapy. (A) Schematic representation of an aptamer-modified viral carrier for potential application in targeted gene delivery. (B) A schematic illustration of a chimeric aptamersiRNA as ApDC for targeted siRNA delivery.